096530.KQ
Seegene, Inc.
KOE · Healthcare · Medical - Specialties · KR
KRW 31,550.00
−1.71%Year over year
Reported trailing growth
- Revenue
- +12.1%
- EBITDA
- +8.5%
- EBIT
- +285.3%
- EPS
- +676.1%
- Free cash flow
- +43.5%
- Operating cash flow
- +38.3%
Forward estimates
Based on analyst estimates
- Revenue
- -44.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -17.8%
- EBITDA
- -28.0%
- EBIT
- -44.0%
- Net income
- -35.7%
- EPS
- -33.7%
- Free cash flow
- -23.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026